Felty Syndrome: Causes, Symptoms & Treatment
Felty syndrome is a rare complication of rheumatoid arthritis characterized by an enlarged spleen and low neutrophil count, significantly increasing the risk of infections.
Things worth knowing about "Felty syndrome"
Felty syndrome is a rare complication of rheumatoid arthritis characterized by an enlarged spleen and low neutrophil count, significantly increasing the risk of infections.
What is Felty Syndrome?
Felty syndrome is a rare and severe variant of rheumatoid arthritis (RA). It is defined by a classic triad of three key features: rheumatoid arthritis, an enlarged spleen (splenomegaly), and a reduced number of neutrophils in the blood (neutropenia). The condition affects fewer than 1% of patients with rheumatoid arthritis and is more common in women than men, typically presenting in middle to older age. It was first described in 1924 by the American physician Augustus Roi Felty.
Causes and Risk Factors
The exact causes of Felty syndrome are not yet fully understood. It is believed that an autoimmune reaction plays a central role, in which the immune system mistakenly attacks the body's own neutrophils in the blood and bone marrow.
- Long-standing, severe rheumatoid arthritis (usually present for more than 10 years)
- High levels of rheumatoid factor in the blood
- Specific genetic markers, particularly the HLA-DR4 antigen
- Female sex and older age
- Rheumatoid nodules and other extra-articular manifestations of RA
Symptoms
The symptoms of Felty syndrome are diverse and reflect both the underlying rheumatoid arthritis and the consequences of neutropenia:
- Joint pain and swelling typical of rheumatoid arthritis
- Enlarged spleen (splenomegaly), sometimes felt as pressure or fullness in the upper left abdomen
- Frequent and severe infections, especially bacterial infections of the respiratory tract and skin, due to the lack of neutrophils
- Enlarged lymph nodes (lymphadenopathy)
- General fatigue, weight loss, and fever
- Skin changes such as brown pigmentation on the legs
- Occasionally an enlarged liver (hepatomegaly)
Diagnosis
The diagnosis of Felty syndrome is based on identifying the characteristic triad along with laboratory tests and imaging:
- Complete blood count: Demonstrating neutropenia (neutrophils below 1,800 cells per microliter of blood)
- Rheumatoid factor and anti-CCP antibodies: Usually significantly elevated
- Abdominal ultrasound or CT scan: To assess the size of the spleen and liver
- Bone marrow biopsy: In unclear cases to evaluate blood cell production
- Exclusion of other causes of neutropenia and splenomegaly (e.g., infections, other hematological disorders)
Treatment
Treatment of Felty syndrome aims to control the underlying rheumatoid arthritis and improve neutrophil counts in order to reduce the risk of infection.
Medical Therapy
- Methotrexate (MTX): Considered the first-line treatment and can significantly improve neutrophil counts
- Biologics: Particularly TNF-alpha inhibitors (e.g., etanercept, infliximab) show good efficacy in controlling RA and neutropenia
- G-CSF (granulocyte colony-stimulating factor): May be used in severe neutropenia to temporarily increase neutrophil counts
- Corticosteroids for short-term anti-inflammatory management
Surgical Therapy
In severe cases with marked splenomegaly and treatment-resistant neutropenia, surgical removal of the spleen (splenectomy) may be considered. This can durably improve neutrophil counts, though it does not address the underlying autoimmune disease.
Infection Management
Due to the increased susceptibility to infection, regular vaccinations (e.g., against pneumococcus and influenza) and prompt treatment of infections are especially important for patients with Felty syndrome.
Prognosis
The prognosis of Felty syndrome is variable. With modern immunosuppressive therapy, particularly methotrexate and biologics, the condition can be well managed in many patients. The greatest risk lies in recurrent severe infections, which can be life-threatening without consistent treatment. Regular medical follow-up is essential.
References
- Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia associated with Felty syndrome. Leukemia and Lymphoma. 1996;23(3-4):261-266. PubMed PMID: 9031105.
- Doran MF, Crowson CS, Pond GR, et al. Predictors of infection in rheumatoid arthritis. Arthritis & Rheumatism. 2002;46(9):2294-2300.
- Firestein GS, Budd RC, Gabriel SE, et al. Kelley & Firestein's Textbook of Rheumatology, 10th ed. Elsevier, 2017.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Felty syndrome